LETICIA WANDLER: Open Payments
NPI 1376147397 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 10 payments from 7 companies in 2025. Trend: 2023 $691 · 2024 $1,764 · 2025 $1,020
Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $283 |
| GENZYME CORPORATION | 2 | $221 |
| United Therapeutics Corporation | 1 | $128 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Verona Pharma, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $106 |
| Grifols USA, LLC | 1 | $32 |
Products named: FASENRA, DUPIXENT, NUCALA, Ohtuvayre, OFEV, Prolastin-C Liquid.
Industry payments across WI — which companies pay providers there.
